Could pre-diabetes be considered a clinical condition? opinions from an endocrinologist and a cardiologist.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 2823595)

Published in Diabetol Metab Syndr on January 15, 2010

Authors

Maria Eliane C Magalhães1, Breno A Cavalcanti, Saulo Cavalcanti

Author Affiliations

1: Division of Cardiology, State University of Rio de Janeiro, Rio de Janeiro, Brazil.

Articles citing this

Type 2 Diabetes Risk among Asian Indians in the US: A Pilot Study. Nurs Res Pract (2013) 0.75

Articles cited by this

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 95.79

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09

Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (2003) 20.07

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes (2003) 16.62

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32

Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 14.03

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes (1979) 12.35

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes (2009) 8.70

Diagnosis and classification of diabetes mellitus. Diabetes Care (2008) 8.16

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet (2002) 5.77

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care (1999) 5.37

Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care (2006) 4.72

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes (2005) 2.80

Normal fasting plasma glucose and risk of type 2 diabetes diagnosis. Am J Med (2008) 2.63

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care (2003) 2.50

Identification of individuals with insulin resistance using routine clinical measurements. Diabetes (2005) 2.46

Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diabetes Care (1992) 2.34

Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev (2001) 2.22

The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J (2006) 1.88

Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arterioscler Thromb Vasc Biol (2003) 1.86

Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia (2009) 1.85

Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care (2001) 1.72

Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 1.67

The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions. Diabet Med (2007) 1.49

The epidemiology of impaired glucose tolerance and hypertension. Am Heart J (1991) 1.38

[V Brazilian Guidelines in Arterial Hypertension. ]. Arq Bras Cardiol (2007) 1.30

The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus. Diabetes Care (1998) 1.20

Coronary artery calcification in type 2 diabetes and insulin resistance: the framingham offspring study. Diabetes Care (2002) 1.16

Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur Heart J (2006) 1.13

Prevalence of diabetes mellitus and impaired glucose tolerance in the urban population aged 30-69 years in Ribeirão Preto (São Paulo), Brazil. Sao Paulo Med J (2003) 1.12

Randomized controlled trial of a new dietary education program to prevent type 2 diabetes in a high-risk group of Japanese male workers. Diabetes Care (2003) 1.06

Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil. Diabetol Metab Syndr (2009) 0.98

Intimal media thickness, glucose intolerance and metabolic syndrome in Asian Indians--the Chennai Urban Rural Epidemiology Study (CURES -22). Diabet Med (2006) 0.83

Association of high sensitivity C-reactive protein (hsCRP) and tumour necrosis factor-alpha (TNF-alpha) with carotid intimal medial thickness in subjects with different grades of glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES-31). Clin Biochem (2008) 0.81